BIOGEN INC.
BIIBSEC CIK 875045Price charts ↗
Writing the earnings story…
Financials
Revenue+1.9% YoY
$2.48B
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Net Income+32.8% YoY
$319.5M
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
EPS (diluted)+31.1% YoY
$2.15
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Gross Margin
—
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
| Quarter ending | Revenue | Net income | EPS |
|---|---|---|---|
| Mar 2026 | $2.48B | $319.5M | $2.15 |
| Sep 2025 | $2.53B | $466.5M | $3.17 |
| Jun 2025 | $2.65B | $634.8M | $4.33 |
| Mar 2025 | $2.43B | $240.5M | $1.64 |
| Sep 2024 | $2.47B | $388.5M | $2.66 |
| Jun 2024 | $2.46B | $583.6M | $4 |
| Mar 2024 | $2.29B | $393.4M | $2.7 |
| Sep 2023 | $2.53B | -$68.1M | -$0.47 |
Annual revenue
FY21FY22FY23FY24FY25
Source filings
Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.
Quarterly report (10-Q)Filed 2026-04-29 · period ending 2026-03-31Open ↗Annual report (10-K)Filed 2026-02-06 · period ending 2025-12-31Open ↗Quarterly report (10-Q)Filed 2025-10-30 · period ending 2025-09-30Open ↗Quarterly report (10-Q)Filed 2025-07-31 · period ending 2025-06-30Open ↗Quarterly report (10-Q)Filed 2025-05-01 · period ending 2025-03-31Open ↗Annual report (10-K)Filed 2025-02-12 · period ending 2024-12-31Open ↗Quarterly report (10-Q)Filed 2024-10-30 · period ending 2024-09-30Open ↗Quarterly report (10-Q)Filed 2024-08-01 · period ending 2024-06-30Open ↗
Glossary
- Revenue
- Net income
- EPS
- Gross margin
- Net margin
- Fiscal year
Hover any underlined term for its definition.